We are live on ! Find out more
BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

84 hedge funds and large institutions have $216M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 19

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less funds holding

Funds holding: 96 → 84 (-12)

18% less capital invested

Capital invested by funds: $263M → $216M (-$47M)

36% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 33

86% less call options, than puts

Call options by funds: $354K | Put options by funds: $2.48M

Holders
84
Holders Change
-12
Holders Change %
-12.5%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
39
Reduced
19
Closed
33
Calls
$354K
Puts
$2.48M
Net Calls
-$2.13M
Net Calls Change
-$789K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.59M
2
JP Morgan Chase
JP Morgan Chase
New York
+$2.83M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.8M
4
NI
Numeric Investors
Massachusetts
+$1.21M
5
Goldman Sachs
Goldman Sachs
New York
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$8.04M
2
KCM
Kennedy Capital Management
Missouri
-$6.53M
3
FCMI
Foresite Capital Management III
California
-$5.78M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.12M
5
QF
QVT Financial
New York
-$3.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
TWA
76
TCI Wealth Advisors
Arizona
$6K -$1.24K -10 -17%
LTFS
77
Ladenburg Thalmann Financial Services
Florida
$6K – – –
BFEC
78
Benjamin F. Edwards & Company
Missouri
$4K -$1.24K -10 -25%
VCM
79
Vigilant Capital Management
Maine
$4K +$3.72K +30 New
PMFA
80
Plante Moran Financial Advisors
Michigan
$4K +$4.34K +35 New
Citigroup
81
Citigroup
New York
$2K +$248 +2 +13%
MA
82
MUFG Americas
New York
$2K +$869 +7 +88%
MAM
83
Meeder Asset Management
Ohio
$1K -$2.73K -22 -67%
MIM
84
Macroview Investment Management
Maryland
$1K +$869 +7 New
Franklin Resources
85
Franklin Resources
California
– -$8.04M -65,180 Closed
QF
86
QVT Financial
New York
– -$3.71M -30,072 Closed
LP
87
LMR Partners
United Kingdom
– -$3.34M -27,059 Closed
Renaissance Technologies
88
Renaissance Technologies
New York
– -$2.8M -22,720 Closed
UONDDL
89
University of Notre Dame du Lac
Indiana
– -$2.6M -21,026 Closed
Ameriprise
90
Ameriprise
Minnesota
– -$2.38M -19,250 Closed
EU
91
Emory University
Georgia
– -$2.03M -16,461 Closed
EAM
92
Eventide Asset Management
Massachusetts
– -$1.6M -13,000 Closed
ACA
93
Avoro Capital Advisors
New York
– -$1.54M -12,500 Closed
PA
94
Perceptive Advisors
New York
– -$1.06M -8,620 Closed
SM
95
Sabby Management
Florida
– -$895K -7,250 Closed
SCM
96
Suffolk Capital Management
New York
– -$784K -6,353 Closed
CC
97
Clearline Capital
New York
– -$681K -5,520 Closed
PRCM
98
Pine River Capital Management
Minnesota
– -$617K -5,000 Closed
Capital Fund Management (CFM)
99
Capital Fund Management (CFM)
France
– -$539K -4,370 Closed
WA
100
Wasatch Advisors
Utah
– -$377K -3,053 Closed
1 2 3
4
5

BLCM Hedge Fund Activity: Q2 2017 in Review

84 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bellicum Pharmaceuticals, Inc. (BLCM) for Q2 2017, worth a combined $216M — down 18% from $263M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of BLCM and 21 opened new positions — a net loss of 12 holders — while 19 trimmed existing stakes and 39 added.

The largest buyer was BlackRock, adding an estimated $6.59M. The largest seller was Franklin Resources, exiting entirely with an estimated $8.04M sold.

  • 84 institutional investors held Bellicum Pharmaceuticals, Inc. (BLCM) as of Q2 2017, down from 96 in Q1 2017.
  • Funds reported $216M of Bellicum Pharmaceuticals, Inc. stock for Q2 2017, down 18% quarter-over-quarter.
  • 21 funds opened new Bellicum Pharmaceuticals, Inc. positions in Q2 2017 and 33 closed out, a net change of -12 holders.
  • The largest Bellicum Pharmaceuticals, Inc. buyer in Q2 2017 was BlackRock, an estimated $6.59M added.
  • The largest Bellicum Pharmaceuticals, Inc. seller in Q2 2017 was Franklin Resources, an estimated $8.04M sold.

Based on aggregated 13F filings for Q2 2017.